Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
Clinical trial NCT02982694 · TERMINATED
Trial details
- NCT number
- NCT02982694
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-24
- Primary completion
- 2020-11-27
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.